Rajesh Malik - 02 Jun 2022 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Director
Signature
/s/ William L. Demers, by Power of Attorney for Rajesh Malik
Issuer symbol
PNT
Transactions as of
02 Jun 2022
Transactions value $
$0
Form type
4
Filing time
06 Jun 2022, 16:03:29 UTC
Previous filing
02 Feb 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +25,614 $0 25,614 02 Jun 2022 Common Stock 25,614 $8.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest 100% on the first anniversary of the grant date.